Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-18

Clinical Trial Update: Efficacy & Safety of Oral Adjuvants to Phototherapy in Neonatal Hyperbilirubinemia [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating oral adjuvants added to phototherapy for neonatal hyperbilirubinemia. Recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Amira Adel Fouly | Conditions: Neonatal Hyperbilirubinemia | Phase 4 | Status: RECRUITING